Literature DB >> 24026640

Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism.

Lingcong Wang1, Jiannong Wu, Wei Zhang, Yihui Zhi, Yanchun Wu, Ronglin Jiang, Ruhui Yang.   

Abstract

Inflammation contributes to acute pulmonary embolism (APE). However, the contributions of the extracellular signal‑regulated protein kinases (ERK) and phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling pathways have not yet been elucidated. The aim of this study was to examine the effects of aspirin on ERK and PI3K/Akt signaling in a rat model of APE and evaluate the prognostic values of brain natriuretic peptide (BNP), troponin (TnT) and D‑Dimer. A total of 108 Sprague‑Dawley rats were assigned into the control, sham, model and low‑, medium‑ and high‑dose aspirin (150, 300 and 600 mg/kg, respectively) groups. In each group, six rats were sacrificed 6, 24 and 72 h subsequent to the induction of APE to collect the lungs and serum. Western blot analysis was used to assess ERK, PI3K and Akt expression; enzyme‑linked immunosorbent assay (ELISA) was used to analyze BNP, TnT and D‑Dimer levels; and changes in lung pathology were evaluated using hematoxylin and eosin (H&E) staining. The results showed that ERK and PI3K levels were decreased in the control, sham and the three aspirin groups at all time‑points compared with the model group (P<0.01). The exception was in the medium‑dose aspirin group at 24 h. The serum levels of BNP, TnT and D‑Dimer were lower in the control and sham groups at all time‑points compared with the model group (P<0.05). Furthermore, the levels of BNP, TnT and D‑Dimer levels were decreased in the aspirin‑treated groups (P<0.05) and markedly increased in the model group (P<0.05) at 24 h compared with the levels at 6 h. Pulmonary embolism, alveolar wall necrosis and hemorrhage were observed in the model group 6, 24 and 72 h subsequent to the induction of the model. However, congestion and inflammation were attenuated following aspirin treatment. In conclusion, aspirin reduces lung damage and improves prognosis. Decreased ERK, PI3K and Akt expression in the lungs and reduced levels of BNP, TnT and D‑Dimer may be important factors in the effects observed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026640     DOI: 10.3892/mmr.2013.1676

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

2.  MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism.

Authors:  Ran Zhu; Wei-Yi Qi; Ting-Wei Liu; Fan Liu
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

3.  Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells.

Authors:  Ronglin Jiang; Liling Wei; Meifei Zhu; Jiannong Wu; Lingcong Wang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

4.  Effects of aspirin on the expression of nuclear factor-κB in a rat model of acute pulmonary embolism.

Authors:  Ling-Cong Wang; Rong-Lin Jiang; Wei Zhang; Li-Ling Wei; Ru-Hui Yang
Journal:  World J Emerg Med       Date:  2014

5.  Deficiency of myotubularin-related protein 14 influences body weight, metabolism, and inflammation in an age-dependent manner.

Authors:  Yin Lv; Lu Xue; Congli Cai; Qing-Hua Liu; Jinhua Shen
Journal:  Cell Biosci       Date:  2015-12-21       Impact factor: 7.133

6.  Inhibition of cAMP-Dependent PKA Activates β2-Adrenergic Receptor Stimulation of Cytosolic Phospholipase A2 via Raf-1/MEK/ERK and IP3-Dependent Ca2+ Signaling in Atrial Myocytes.

Authors:  M R Pabbidi; X Ji; J T Maxwell; G A Mignery; A M Samarel; S L Lipsius
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

Review 7.  Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.

Authors:  Andrei A Karpov; Dariya D Vaulina; Sergey S Smirnov; Olga M Moiseeva; Michael M Galagudza
Journal:  Heliyon       Date:  2022-02-24

8.  Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor.

Authors:  Ran Zhu; Ting-Wei Liu; Fan Liu
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

9.  Alterations in Energy Metabolism, Mitochondrial Function and Redox Homeostasis in GK Diabetic Rat Tissues Treated with Aspirin.

Authors:  Annie John; Layla Amiri; Jasmin Shafarin; Saeed Tariq; Ernest Adeghate; Frank Christopher Howarth; Haider Raza
Journal:  Life (Basel)       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.